Live from the NIH registry
Studies recruiting near Ogden right now
Top 25 of 113 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Adaptation and Pilot Implementation of ePNa Clinical Decision Support for Utah Urgent Care Clinics
Pneumonia
N/A
Interventional 4,000 participants sought
South Ogden Instacare — South Ogden, Utah (2.5 mi)
· Sponsor: Intermountain Health Care, Inc.
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Advanced Research Institute /ID# 259821 — Ogden, Utah (0.4 mi)
· Sponsor: AbbVie
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Farmington Health Center — Farmington, Utah (17.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
Respiration, Artificial
N/A
Interventional 13,400 participants sought
Mckay Dee Hospital — Ogden, Utah (0.4 mi)
· Sponsor: Intermountain Health Care, Inc.
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Farmington Health Center — Farmington, Utah (17.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Ogden, Utah (0.4 mi)
· Sponsor: 89bio, Inc.
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Colon Adenocarcinoma, Rectal Adenocarcinoma
Phase 3
Interventional 477 participants sought
Community Cancer Trials of Utah ( Site 0086) — Ogden, Utah (0.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
Pneumococcal Disease
Phase 3
Interventional 1,200 participants sought
AMR Clinical — Syracuse, Utah (10.8 mi)
· Sponsor: Pfizer
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12153 — South Ogden, Utah (2.5 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: NRG Oncology
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Advanced Research Institute - Ogden — Ogden, Utah (0.4 mi)
· Sponsor: vTv Therapeutics
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
COVID-19 SARS-CoV-2 Infection
Phase 3
Interventional 2,330 participants sought
Alpine Research Organization — Clinton, Utah (7.4 mi)
· Sponsor: Pfizer
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Hypertriglyceridemia
Phase 3
Interventional 869 participants sought
Research Site 15 — Bountiful, Utah (23.8 mi)
· Sponsor: Arrowhead Pharmaceuticals
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 220 participants sought
START Mountain — Ogden, Utah (0.4 mi)
· Sponsor: Vividion Therapeutics, Inc.
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Cope Family Medicine-Site Number : 8400053 — Bountiful, Utah (23.8 mi)
· Sponsor: Sanofi
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
Alpine Research Organization — Clinton, Utah (7.4 mi)
· Sponsor: Eli Lilly and Company
An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease
Dry Eye Disease (DED)
Phase 2
Interventional 417 participants sought
Alpine Research Organization, Inc. — Clinton, Utah (7.4 mi)
· Sponsor: Dompé Farmaceutici S.p.A
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Phase 3
Interventional 1,200 participants sought
Research Site — Bountiful, Utah (23.8 mi)
· Sponsor: AstraZeneca
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Crohn's Disease
Phase 2
Interventional 540 participants sought
Care Access - Ogden /ID# 266428 — Ogden, Utah (0.4 mi)
· Sponsor: AbbVie
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: NRG Oncology
Evaluation of Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center Registry
Otitis Media With Effusion, Acute Otitis Media
N/A
Observational 200 participants sought
Ogden Clinic - Professional Center North — Ogden, Utah (0.4 mi)
· Sponsor: Smith & Nephew, Inc.
Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients
Correction Vision Surgery, Cataract Surgery
N/A
Observational 35 participants sought
Utah Eye Centers — Ogden, Utah (0.4 mi)
· Sponsor: Utah Eye Centers
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400007 — Ogden, Utah (0.4 mi)
· Sponsor: Sanofi
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Layton, Utah (11.6 mi)
· Sponsor: Alnylam Pharmaceuticals